oxazoles has been researched along with 3-nitrotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haddon, CO; Iravani, MM; Jenner, P; Leung, CC; Rose, S; Sadeghian, M | 1 |
Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Siracusa, R | 1 |
2 other study(ies) available for oxazoles and 3-nitrotyrosine
Article | Year |
---|---|
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Topics: Amphetamine; Animals; Behavior, Animal; CD11b Antigen; Cell Count; Diagnostic Imaging; Dopamine; Dopamine Uptake Inhibitors; Drug Interactions; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lipopolysaccharides; Motor Activity; Neuroglia; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxazoles; Rats; S100 Proteins; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 2005 |
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Behavior, Animal; Cyclooxygenase 2; Cytokines; Disease Models, Animal; DNA Damage; Dopamine Plasma Membrane Transport Proteins; Inflammation; Mice, Inbred C57BL; Microglia; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Nitrosative Stress; Oxazoles; Oxidative Stress; Parkinson Disease; Poly Adenosine Diphosphate Ribose; Transcription Factor RelA; Tyrosine; Tyrosine 3-Monooxygenase | 2018 |